Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06162663 | Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors | terminated | Phase 4 | 6 | Medical University of South CarolinaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05183828 | Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer | terminated | Phase 4 | 62 | University of WashingtonOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT02688803 | Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)(OTT15-04) | terminated | Phase 4 | 2 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05807074 | Impact of Topical Tranexamic Acid in Breast Reconstruction | terminated | Phase 4 | 23 | University of California, San FranciscoOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT04657679 | Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts(LEANORA) | terminated | Phase 4 | 21 | Georgetown UniversityOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT04625517 | Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM) | terminated | Phase 4 | 6 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | terminated | Phase 4 | 4 | Eli Lilly and CompanyINDUSTRY | 2 | Aug 24, 2021 | clinicaltrials |
| NCT03456661 | Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block | terminated | Phase 4 | 40 | University Hospital, AntwerpOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT00754767 | L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer | terminated | Phase 4 | 2 | HealthPartners InstituteOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT00087620 | A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer | terminated | Phase 4 | — | Hoffmann-La RocheINDUSTRY | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00699101 | Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy | terminated | Phase 4 | 342 | SenoRx, Inc.INDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00241046 | Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment | terminated | Phase 4 | 13 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 19, 2012 | clinicaltrials |
| NCT00171847 | Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer(eLEcTRA) | terminated | Phase 4 | 93 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 31, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials